These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30390949)

  • 1. No. 365-Fetal and Perinatal Autopsy in Prenatally Diagnosed Fetal Abnormalities with Normal Chromosome Analysis.
    Fallet-Bianco C; De Bie I; Désilets V; Oligny LL
    J Obstet Gynaecol Can; 2018 Oct; 40(10):1358-1366.e5. PubMed ID: 30390949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal and perinatal autopsy in prenatally diagnosed fetal abnormalities with normal karyotype.
    Désilets V; Oligny LL; ; ;
    J Obstet Gynaecol Can; 2011 Oct; 33(10):1047-57. PubMed ID: 22014783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of prenatally diagnosed structural congenital anomalies.
    Gagnon A;
    J Obstet Gynaecol Can; 2009 Sep; 31(9):875-881. PubMed ID: 19941713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal Diagnosis Procedures and Techniques to Obtain a Diagnostic Fetal Specimen or Tissue: Maternal and Fetal Risks and Benefits.
    Wilson RD; Gagnon A; Audibert F; Campagnolo C; Carroll J;
    J Obstet Gynaecol Can; 2015 Jul; 37(7):656-668. PubMed ID: 26366824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcomes after assisted human reproduction.
    Okun N; Sierra S; ;
    J Obstet Gynaecol Can; 2014 Jan; 36(1):64-83. PubMed ID: 24444289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
    Langlois S; Duncan A; ;
    J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No. 380-Investigation and Management of Prenatally Identified Microcephaly.
    De Bie I; Boucoiran I
    J Obstet Gynaecol Can; 2019 Jun; 41(6):855-861. PubMed ID: 31126434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No. 363-Investigation and Management of Non-immune Fetal Hydrops.
    Désilets V; De Bie I; Audibert F
    J Obstet Gynaecol Can; 2018 Aug; 40(8):1077-1090. PubMed ID: 30103882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent Pregnancy Guidelines.
    Fleming N; O'Driscoll T; Becker G; Spitzer RF;
    J Obstet Gynaecol Can; 2015 Aug; 37(8):740-756. PubMed ID: 26474231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Umbilical Cord Blood: Counselling, Collection, and Banking.
    Armson BA; Allan DS; Casper RF
    J Obstet Gynaecol Can; 2015 Sep; 37(9):832-844. PubMed ID: 26605456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound in twin pregnancies.
    Morin L; Lim K; ; ; ;
    J Obstet Gynaecol Can; 2011 Jun; 33(6):643-656. PubMed ID: 21846456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No. 261-Prenatal Screening for Fetal Aneuploidy in Singleton Pregnancies.
    Chitayat D; Langlois S; Wilson RD
    J Obstet Gynaecol Can; 2017 Sep; 39(9):e380-e394. PubMed ID: 28859781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance use in pregnancy.
    Wong S; Ordean A; Kahan M; ; ; ; ;
    J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol use and pregnancy consensus clinical guidelines.
    Carson G; Cox LV; Crane J; Croteau P; Graves L; Kluka S; Koren G; Martel MJ; Midmer D; Nulman I; Poole N; Senikas V; Wood R;
    J Obstet Gynaecol Can; 2010 Aug; 32(8 Suppl 3):S1-31. PubMed ID: 21172102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity in pregnancy.
    Davies GAL; Maxwell C; McLeod L; ;
    J Obstet Gynaecol Can; 2010 Feb; 32(2):165-173. PubMed ID: 20181319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for the management of vasa previa.
    Gagnon R; ;
    J Obstet Gynaecol Can; 2009 Aug; 31(8):748-753. PubMed ID: 19772710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes.
    Audibert F; De Bie I; Johnson JA; Okun N; Wilson RD; Armour C; Chitayat D; Kim R
    J Obstet Gynaecol Can; 2017 Sep; 39(9):805-817. PubMed ID: 28859766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.